Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AMP-activated protein kinase alpha (AMPKα) is the catalytic subunit of the heterotrimeric AMPK complex, which functions as the primary energy sensor and master regulator of metabolic homeostasis in eukaryotic cells [1, 4, 5]. It is activated in response to energy stress, signaled by increased cellular AMP:ATP or ADP:ATP ratios, as well as by upstream kinases like LKB1 and CaMKKβ that phosphorylate the conserved Thr-172 residue within its activation loop [1, 10, 13, 16]. Upon activation, AMPKα coordinates a metabolic switch from energy-consuming anabolic processes (such as lipid, cholesterol, and protein synthesis) to energy-producing catabolic pathways (such as glucose uptake and fatty acid oxidation) to restore cellular energy balance [5, 16, 21]. Due to its central role in glucose and lipid metabolism, AMPKα is a major therapeutic target for metabolic diseases, including type 2 diabetes, obesity, and non-alcoholic fatty liver disease [3, 5, 12, 21]. Furthermore, its ability to inhibit the mTOR signaling pathway and regulate the cell cycle makes it a significant target of interest in oncology and cardiovascular health research [3, 11, 16, 17, 21].
Activation of the AMPK complex through allosteric binding of AMP/ADP or small molecule agonists (direct or indirect), leading to the phosphorylation of the alpha-subunit at Thr-172, which triggers downstream phosphorylation of metabolic enzymes to enhance catabolism and inhibit anabolism [1, 6, 13, 16, 21].
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AMP-activated protein kinase catalytic subunit alpha (AMPKα) (AMPKα).